Showing results (11-20 of 308) with videos related to
Sort By:
Pageof 31
Therapeutic Drug Monitoring|January 1, 1988
Clinical assessment of a two-compartment Bayesian forecasting method for lidocaineC L Beach, J A Farringer, C C Peck, et al.Journal of Pharmaceutical Sciences|July 1, 1984
Plasma protein binding of warfarin: methodological considerationsD Mungall, Y Y Wong, R L Talbert, et al.Journal of Pharmaceutical Sciences|September 1, 1988
Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjectsT M Ludden, D A Boyle, D Gieseker, et al.European Journal of Clinical Pharmacology|January 1, 1993
Bioavailability of controlled release carbamazepine estimated by mixed effect modellingR Miller, T M LuddenComputers in Biology and Medicine|May 1, 1995
A spreadsheet program for simulation of bioequivalence and bioavailability studiesH Y Abdallah, T M LuddenPharmaceutical Research|December 1, 1995
Population pharmacokinetic modeling: the importance of informative graphicsE I Ette, T M LuddenJournal of Pharmaceutical Sciences|August 1, 1986
High-performance liquid chromatographic assay for etoposide in human plasmaM R Hersh, T M LuddenJournal of Chromatography|December 14, 1990
Determination of betaxolol and its metabolites in blood and urine by high-performance liquid chromatography with fluorimetric detectionY W Wong, T M LuddenJournal of Pharmacokinetics and Biopharmaceutics|December 1, 1996
On the recording of sample times and parameter estimation from repeated measures pharmacokinetic dataH Sun, E I Ette, T M LuddenJournal of Clinical Pharmacology|April 29, 1998
Ignorability and parameter estimation in longitudinal pharmacokinetic studiesE I Ette, H Sun, T M LuddenPageof 31